This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sanfelippo, P. M. Search for Related Content PubMed PubMed Citation Articles by Sanfelippo, P. M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Thinners Platelet Disorders Hazardous Substances DB HEPARIN Social Bookmarking                         What's this?

Heparin-Induced Thrombocytopenia—A Potential Iatrogenic Complication for Patients with Cardiac and Vascular Disease

Cardiovascular and Thoracic Surgery, University of Texas Health Center at Tyler, Tyler, TX, petersanfelippo{at}aol.com

Physicians involved in the care of patients with cardiac and vascular problems regularly employ heparin in treatment regimens of inpatients and outpatients. Heparin-induced thrombocytopenia is an important complication that can result in significant morbidity and mortality. It is reasonable, therefore, to review the pathogenetic mechanisms involved, the identification of heparin-induced thrombocytopenia, and the management to minimize morbidity and mortality.

Angiology, Vol. 56, No. 3, 305-309 (2005)
DOI: 10.1177/000331970505600310


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?